Della Belatti
- Democratic
- Representative
- District 26
Primary
Beginning on 1/1/2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 7/1/3000. (HD1)
Passed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) Nakashima, Nishimoto, Sayama, Ward excused (4).
Reported from HLT (Stand. Com. Rep. No. 199-24) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Belatti, Takenouchi, Amato, Ilagan, Kobayashi, Marten, Nishimoto, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
Bill scheduled to be heard by HLT on Wednesday, 02-07-24 9:45AM in House conference room 329 VIA VIDEOCONFERENCE.
Carried over to 2024 Regular Session.
Referred to HLT, CPC, FIN, referral sheet 3
Introduced and Pass First Reading.
Pending introduction.
| Bill Text Versions | Format |
|---|---|
| HB966_HD1 | PDF HTML |
| HB966 | PDF HTML |
| Document | Format |
|---|---|
| No related documents. |
Data on Open States is updated periodically throughout the day from the official website of the Hawaii State Legislature.
If you notice any inconsistencies with these official sources, feel free to file an issue.